WASHINGTON — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Trump’s administration is causing alarm across the agency, stoking ...
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
2d
Trump eased restrictions on research for ibogaine. Here's what to know about the psychedelic drug.
President Donald Trump on Saturday signed an executive order aimed at expanding research into a psychedelic drug called ...
Dr. Marty Makary, commissioner of the Food and Drug Administration, speaks at an event on addiction recovery in the Oval Office of the White House, Thursday, Jan. 29, 2026, in Washington, as Attorney ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29 ...
As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...
Ronald Schneider, B.S.Pharm., M.H.A.; Jonathan Bagby, R.N., M.B.A., M.S.N.; Russ Carlson, R.N., B.S.N., M.H.A. Am J Health Syst Pharm. 2008;65(23):2216-2219. In 1994 ...
The Drug Enforcement Administration organizes the month of April and specific days as “Drug Take Back Day” promoting a safe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results